We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-0.91%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$117B
AUM Growth
-$6.8B
(-5.5%)
Cap. Flow
-$1.96B
Cap. Flow
% of AUM
-1.67%
Top 10 Holdings %
Top 10 Hldgs %
30.2%
Holding
4,248
New
63
Increased
1,950
Reduced
1,821
Closed
101
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRSH
Marsh
MRSH
|
+$162M |
| 2 |
Vertiv
VRT
|
+$52.4M |
| 3 |
Palo Alto Networks
PANW
|
+$34.3M |
| 4 |
Waters Corp
WAT
|
+$21.5M |
| 5 |
Pinnacle Financial Partners Inc
PNFP
|
+$20.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 3000 ETF
IWV
|
+$607M |
| 2 |
Apple
AAPL
|
+$186M |
| 3 |
Microsoft
MSFT
|
+$139M |
| 4 |
Meta Platforms (Facebook)
META
|
+$89.6M |
| 5 |
NVIDIA
NVDA
|
+$74.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.6% |
| 2 | Financials | 12.67% |
| 3 | Consumer Discretionary | 10.32% |
| 4 | Industrials | 10.12% |
| 5 | Healthcare | 9.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
Arvinas
ARVN
$530M
| $853K | ﹤0.01% |
80,492
-6,704
| -8% | -$83K |
|
2177
Kura Oncology
KURA
$901M
| $852K | ﹤0.01% |
104,815
+368
| +0.4% | +$3.16K |
|
2178
First Community Bankshares
FCBC
$909M
| $849K | ﹤0.01% |
20,439
-259
| -1% | -$9.86K |
|
2179
Clover Health Investments
CLOV
$2.25B
| $846K | ﹤0.01% |
480,859
-2,531
| -0.5% | -$5.49K |
|
2180
Ultrapar
UGP
$6.71B
| $845K | ﹤0.01% |
153,417
-1,551
| -1% | -$7.5K |
|
2181
Forum Energy Technologies
FET
$640M
| $845K | ﹤0.01% |
14,406
-719
| -5% | -$36.5K |
|
|
RHLD
2182
Resolute Holdings Management
RHLD
$1.06B
| $845K | ﹤0.01% |
5,204
-87
| -2% | -$15.9K |
|
2183
Copel
ELPC
$8.57B
| $844K | ﹤0.01% |
70,650
+425
| +0.6% | +$4.52K |
|
2184
Gogo Inc
GOGO
$540M
| $841K | ﹤0.01% |
209,194
-226
| -0.1% | -$1.03K |
|
2185
GSK
GSK
$104B
| $837K | ﹤0.01% |
15,163
-445
| -3% | -$24.1K |
|
2186
ENI
E
$73.5B
| $835K | ﹤0.01% |
14,753
+1,620
| +12% | +$72.6K |
|
2187
NETGEAR
NTGR
$681M
| $835K | ﹤0.01% |
38,220
-1,670
| -4% | -$36K |
|
2188
Stagwell
STGW
$1.92B
| $827K | ﹤0.01% |
131,494
-6,605
| -5% | -$36.9K |
|
2189
Vaalco Energy
EGY
$552M
| $824K | ﹤0.01% |
130,015
-4,596
| -3% | -$23.2K |
|
2190
Washington Trust Bancorp
WASH
$736M
| $823K | ﹤0.01% |
24,605
-3,619
| -13% | -$119K |
|
2191
Tactile Systems Technology
TCMD
$626M
| $823K | ﹤0.01% |
31,495
+2,281
| +8% | +$65.1K |
|
2192
SELLAS Life Sciences
SLS
$2.13B
| $821K | ﹤0.01% |
194,198
+64,889
| +50% | +$290K |
|
2193
Transcat
TRNS
$805M
| $819K | ﹤0.01% |
11,149
-274
| -2% | -$19.3K |
|
|
HTB
2194
HomeTrust Bancshares
HTB
$833M
| $818K | ﹤0.01% |
19,180
-369
| -2% | -$15.9K |
|
2195
Oil-Dri
ODC
$1.43B
| $818K | ﹤0.01% |
12,562
+85
| +0.7% | +$5.17K |
|
|
CTO
2196
CTO Realty Growth
CTO
$744M
| $815K | ﹤0.01% |
44,061
+590
| +1% | +$11K |
|
2197
Vishay Precision Group
VPG
$1.36B
| $814K | ﹤0.01% |
18,741
-158
| -0.8% | -$7.13K |
|
2198
indie Semiconductor
INDI
$727M
| $814K | ﹤0.01% |
252,694
+11,488
| +5% | +$40.6K |
|
2199
ArriVent BioPharma
AVBP
$1.4B
| $811K | ﹤0.01% |
35,148
+3,692
| +12% | +$83.4K |
|
|
BCAX
2200
Bicara Therapeutics
BCAX
$1.83B
| $810K | ﹤0.01% |
40,747
+164
| +0.4% | +$2.82K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2026 Portfolio in Review
As of Q1 2026, RhumbLine Advisers held 4,248 positions worth $117B, down 5.5% from $124B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Trading was light in Q1 2026: portfolio turnover was 3.9%. RhumbLine Advisers opened 63 new positions and exited 101, leaving the 4,248-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
- RhumbLine Advisers's largest Q1 2026 buy was Versant Media Group: 361,319 shares worth $13.4M.
- RhumbLine Advisers added most to Marsh in Q1 2026, an estimated $162M increase.
- RhumbLine Advisers's biggest Q1 2026 reduction was iShares Russell 3000 ETF, cutting an estimated $607M.
- RhumbLine Advisers fully exited Everpure Inc in Q1 2026, selling an estimated $58.7M.
- RhumbLine Advisers's ten largest holdings make up 30% of its $117B portfolio in Q1 2026.
- RhumbLine Advisers opened 63 new positions and closed 101 in Q1 2026.
- RhumbLine Advisers's portfolio value fell 5.5% quarter-over-quarter to $117B.
Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.